首页|Hypotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study

Hypotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study

扫码查看
原文链接
  • NSTL
  • Elsevier
? 2021 Elsevier B.V.Study objectives: To investigate the proportion of inpatients with schizophrenia and major depressive disorder prescribed hypnotic medication, and the association between such medication and the use of other antipsychotic agents. Methods: This was a nationwide cross-sectional study performed as part of the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment’ (EGUIDE) project. Data from 2146 inpatients with schizophrenia and 1031 inpatients with major depressive disorder were analyzed. All types and dosages of psychotropic drugs were recorded and the data at the time of discharge were analyzed. Associations between the use of hypnotic medication and other antipsychotic agents were evaluated using multivariate logistic regression analyses. Results: The proportions of schizophrenia patients who were prescribed any and two or more hypnotic agents were 55.7% and 17.6%, respectively, and the corresponding proportions for patients with major depressive disorder were 63.6% and 22.6%, respectively. In schizophrenia patients, multivariate logistic regression analyses showed that two or more antipsychotics, anticholinergic drugs, anxiolytics, and mood stabilizers/antiepileptic drugs were positively associated with the use of any hypnotic agent. In patients with major depressive disorder, multivariate logistic regression analyses revealed that two or more antidepressants, two or more antipsychotics, anxiolytics, and mood stabilizers/antiepileptic drugs were positively associated with the use of any hypnotic agent. Conclusions: Prescription of hypnotic agents was found to be highly frequent among inpatients with psychiatric disorders. Prescription of two or more main antipsychotic agents was commonly associated with the use of hypnotic medication for both schizophrenia and major depressive disorder.

AntidepressantAntipsychoticHypnotic medicationInsomniaMajor depressive disorderSchizophrenia

Ohi K.、Yasuda Y.、Iida H.、Ogasawara K.、Hashimoto N.、Ichihashi K.、Yamada H.、Watanabe K.、Inada K.、Hashimoto R.、Furihata R.、Otsuki R.、Hasegawa N.、Tsuboi T.、Numata S.、Yasui-Furukori N.、Kashiwagi H.、Hori H.、Ochi S.、Muraoka H.、Onitsuka T.、Komatsu H.、Takeshima M.、Hishimoto A.、Nagasawa T.、Takaesu Y.、Nakamura T.、Asami T.、Miura K.、Matsumoto J.

展开 >

Department of Psychiatry Gifu University Graduate School of Medicine

Department of Pathology of Mental Diseases National Institute of Mental Health National Center of

Department of Psychiatry Faculty of Medicine Fukuoka University

Center for Postgraduate Clinical Training and Career Development Nagoya University Hospital

Department of Psychiatry Hokkaido University Graduate School of Medicine

Department of Neuropsychiatry University of Tokyo Hospital

Department of Neuropsychiatry Kyorin University School of Medicine

Department of Psychiatry Tokyo Women's Medical University

Kyoto University Health Service

Department of Psychiatry Nihon University School of Medicine

Department of Psychiatry Graduate School of Biomedical Science Tokushima University

Department of Psychiatry Dokkyo Medical University School of Medicine

Department of Neuropsychiatry Molecules and Function Ehime University Graduate School of Medicine

Department of Neuroimaging Psychiatry Graduate School of Medical Sciences Kyushu University

Department of Psychiatry Tohoku University Hospital

Department of Neuropsychiatry Akita University Graduate School of Medicine

Department of Psychiatry Yokohama City University Graduate School of Medicine

Department of Neuropsychiatry Kanazawa Medical University

Department of Neuropsychiatry Graduate School of Medicine University of the Ryukyus

Department of Psychiatry Shinshu University School of Medicine

展开 >

2022

10.1016/j.sleep.2021.11.005

Sleep medicine

Sleep medicine

SCI
ISSN：1389-9457
年,卷(期)：2022.89
  • 5
  • 50